...
首页> 外文期刊>Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery >Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
【24h】

Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.

机译:人乳头瘤病毒在未知原发性头颈部鳞状细胞癌的转移淋巴结中。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Determine human papillomavirus (HPV) incidence in unknown primary squamous cell carcinomas (SCCa) of the head and neck and assess if HPV status influenced survival. STUDY DESIGN: Historical cohort study. SETTING: Tertiary care center. SUBJECTS: Patients with unknown primary SCCa despite a complete workup who underwent neck dissection or excisional biopsy and postoperative comprehensive +/- chemoradiotherapy between 2002 and 2009. METHODS: HPV fluorescence in situ hybridization (FISH) and p16(INK4a) immunohistochemistry (p16 IHC) were performed. Results were compared with survival, age, race, gender, tobacco use, alcohol use, and nodal stage. RESULTS: Twenty-five patients met the inclusion criteria, of whom 88% were >10 pack year tobacco users. Twenty-eight percent were HPV-positive defined by both p16+ and FISH+. Five-year overall survival was 66.7% in HPV-positive and 48.5% in HPV-negative patients (P = .35). Similarly, 5-year disease-free survival rates were 66.7% in HPV-positive and 48.5% in HPV-negative patients (P = .54). All 3 HPV-positive nonsmokers were survivors, but this was not significant because of the small sample size (P > .05). No other characteristics were associated with survival (P > .05). CONCLUSION: Twenty-eight percent of metastatic lymph nodes from occult primary tumors were HPV positive. There was no survival difference associated with HPV status. Most of the HPV-positive patients in this study were tobacco users who had similar survival to HPV-negative patients, so caution should be used in interpreting HPV status in these patients.
机译:目的:确定人乳头瘤病毒(HPV)在头颈部未知原发性鳞状细胞癌(SCCa)中的发生率,并评估其是否影响生存。研究设计:历史队列研究。地点:三级护理中心。研究对象:2002年至2009年间,尽管完成了完整的检查但仍未完成原发性SCCa的患者进行了颈部解剖或切除活检,并进行了全面的+/-放化疗。方法:HPV荧光原位杂交(FISH)和p16(INK4a)免疫组织化学(p16 IHC)被执行。将结果与生存期,年龄,种族,性别,吸烟,饮酒和结节阶段进行比较。结果:25名患者符合纳入标准,其中88%是> 10包年的烟草使用者。 p16 +和FISH +定义了28%的HPV阳性。 HPV阳性患者的五年总生存率为66.7%,HPV阴性患者为48.5%(P = 0.35)。同样,HPV阳性患者的5年无病生存率为66.7%,HPV阴性患者为48.5%(P = 0.54)。所有3例HPV阳性非吸烟者均为幸存者,但这并不重要,因为样本量较小(P> .05)。没有其他特征与生存相关(P> 0.05)。结论:隐匿性原发肿瘤转移淋巴结中有28%为HPV阳性。 HPV状态没有生存差异。在这项研究中,大多数HPV阳性患者是吸烟者,其存活率与HPV阴性患者相似,因此在解释这些患者的HPV状况时应谨慎行事。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号